Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Drug Delivery
Marketing
AbbVie pumps up the case for early subcutaneous Parkinson’s care
Delaying the use of subcutaneous Parkinson’s disease treatments by one year increases annual medical costs by 59.1%, AbbVie-sponsored research found.
Nick Paul Taylor
Oct 22, 2026 6:32am
Cosette lands FDA approval for Evoxac liquid in Sjögren’s
Oct 20, 2026 11:22am
BARDA hands Kaléo $96M contract for chemical threat preparedness
Oct 13, 2026 11:02am
Neurotech turns to YouTube for rare eye disorder campaign
Jun 3, 2026 9:32am
J&J bladder cancer survey shows toll of surgery, BCG treatment
May 14, 2026 4:00pm
Biogen taps Alteogen for help developing 2 subQ biologics
Mar 25, 2026 10:55am